Global Cord Blood (NYSE:CO) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Global Cord Blood (NYSE:COGet Rating) in a report issued on Thursday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood stock opened at $2.34 on Thursday. The company has a market cap of $284.43 million, a price-to-earnings ratio of 3.55 and a beta of 0.39. The business’s 50 day simple moving average is $3.34 and its 200 day simple moving average is $3.88. Global Cord Blood has a 12 month low of $2.10 and a 12 month high of $6.31.

Global Cord Blood (NYSE:COGet Rating) last posted its quarterly earnings results on Monday, February 28th. The medical research company reported $0.17 earnings per share (EPS) for the quarter. The business had revenue of $49.78 million during the quarter. Global Cord Blood had a net margin of 41.98% and a return on equity of 11.42%.

Large investors have recently modified their holdings of the stock. National Asset Management Inc. purchased a new stake in Global Cord Blood during the first quarter valued at approximately $39,000. Campbell & CO Investment Adviser LLC purchased a new position in Global Cord Blood during the first quarter valued at $56,000. Two Sigma Advisers LP purchased a new position in shares of Global Cord Blood in the third quarter worth about $58,000. American Century Companies Inc. increased its position in Global Cord Blood by 26.2% during the third quarter. American Century Companies Inc. now owns 20,591 shares of the medical research company’s stock worth $96,000 after purchasing an additional 4,269 shares during the last quarter. Finally, Citadel Advisors LLC increased its position in Global Cord Blood by 10.9% during the fourth quarter. Citadel Advisors LLC now owns 29,704 shares of the medical research company’s stock worth $124,000 after purchasing an additional 2,914 shares during the last quarter. Institutional investors own 15.13% of the company’s stock.

Global Cord Blood Company Profile (Get Rating)

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.

Featured Articles

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.